Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9

Haidy Nasief, William Hall, Cheng Zheng, Susan Tsai, Liang Wang, Beth Erickson, X. Allen Li

Open source

DOI
10.3389/fonc.2019.01464
Published
2020-01-08
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2019.01464,
  title = {Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9},
  author = {Haidy Nasief and William Hall and Cheng Zheng and Susan Tsai and Liang Wang and Beth Erickson and X. Allen Li},
  year = {2020},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2019.01464},
  url = {https://doi.org/10.3389/fonc.2019.01464}
}

RIS

TY  - JOUR
TI  - Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9
AU  - Haidy Nasief
AU  - William Hall
AU  - Cheng Zheng
AU  - Susan Tsai
AU  - Liang Wang
AU  - Beth Erickson
AU  - X. Allen Li
PY  - 2020
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2019.01464
UR  - https://doi.org/10.3389/fonc.2019.01464
ER  - 

APA

Nasief, H., Hall, W., Zheng, C., Tsai, S., Wang, L., Erickson, B., & Li, X. A. (2020). Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9. Frontiers in Oncology. https://doi.org/10.3389/fonc.2019.01464

Source records